# Predicting peptide orientation in membrane interactions: a review on transmembrane and surface-bound states

**Authors:** Lúcio Otávio Nunes

PMC · DOI: 10.1007/s00249-025-01810-7 · European Biophysics Journal · 2026-01-23

## TL;DR

This review explores how to predict whether antimicrobial peptides insert into membranes or stay on the surface, based on their physical and chemical properties.

## Contribution

The paper introduces a systematic framework integrating sequence features and environmental factors to qualitatively predict peptide orientation.

## Key findings

- Peptide orientation can be predicted using sequence-level features, amphipathicity, and helix propensity.
- Environmental factors like pH and ionic strength influence whether peptides remain surface-bound or insert into membranes.
- The framework combines theoretical and experimental data to guide future experimental validation.

## Abstract

Understanding the mechanism of action of antimicrobial peptides (AMPs) is a key step in developing new antimicrobial agents. This mechanism is often linked to the peptide’s orientation upon interaction with lipid membranes—whether it inserts into the membrane or remains surface-bound. Despite its importance, the literature lacks a systematic approach to predict peptide orientation based on physicochemical characteristics. This review highlights how peptide orientation at membranes can be qualitatively predicted by integrating sequence-level features, length/effective span, amphipathicity, charge distribution, and helix propensity, with membrane/environmental variables. The approach is illustrated with representative AMPs and it is discussed how external factors (pH, anionic fraction, cholesterol, ionic strength) bias surface-bound versus transmembrane regimes. The review is built upon theoretical observations and integrates structural, thermodynamic, and electrostatic parameters drawn from experimental data in the literature. While this study does not aim to provide a definitive classification, it offers a starting point that may guide experimental validation and future refinement.

## Full-text entities

- **Genes:** CAMP (cathelicidin antimicrobial peptide) [NCBI Gene 820] {aka CAP-18, CAP18, CRAMP, FALL-39, FALL39, HSD26}
- **Chemicals:** lysine (MESH:D008239), tryptophan (MESH:D014364), hydrogen (MESH:D006859), DPPE (MESH:C043062), Lipid (MESH:D008055), calcein (MESH:C007740), Asp (MESH:D001224), Alamethicin (MESH:D000408), amino acid (MESH:D000596), PC (MESH:C053518), Arg (MESH:D001120), POPG (MESH:C060037), Mg2+ (-), Glu (MESH:D018698), Cholesterol (MESH:D002784), glycine (MESH:D005998), water (MESH:D014867), phospholipid (MESH:D010743), cardiolipin (MESH:D002308), valine (MESH:D014633), peptides (MESH:D010455), dermcidin (MESH:C442243), His (MESH:D006639), POPC (MESH:C065191), ester (MESH:D004952), phosphatidic acid (MESH:D010712), DPPC (MESH:D015060), alanine (MESH:D000409), metal (MESH:D008670), PS (MESH:D010758), AMPs (MESH:D000089882), phosphate (MESH:D010710)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12929272/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12929272/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12929272/full.md

---
Source: https://tomesphere.com/paper/PMC12929272